CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
499,516
466,878
370,407
341,169
296,458
Cost of Revenue
164,491
146,787
125,517
124,034
106,483
Gross Profit
335,025
320,090
244,890
217,135
189,975
Operating Expenses
Research Development
10,624
9,524
6,504
7,022
6,024
Selling General and Administrative
161,002
164,393
102,528
66,198
51,365
Total Operating Expenses
171,626
173,918
109,031
73,220
57,389
Operating Income or Loss
163,399
146,173
135,859
143,915
132,586
Interest Expense
391
338
583
254
1,727
Total Other Income/Expenses Net
7,363
6,462
3,509
2,443
-1,311
Income Before Tax
190,283
166,003
146,408
153,919
135,098
Income Tax Expense
20,665
18,036
64,172
25,126
20,993
Income from Continuing Operations
169,618
147,967
82,236
128,793
114,106
Net Income
147,168
128,056
67,943
104,779
89,043
Net Income available to common shareholders
144,095
128,056
65,754
101,792
86,972
Reported EPS
Basic
-
3.54
2.40
3.79
3.40
Diluted
-
3.53
2.38
3.74
3.27
Weighted average shares outstanding
Basic
-
35,304
27,362
26,848
25,599
Diluted
-
35,433
27,606
27,249
26,567
EBITDA
-
189,567
159,900
166,912
145,860